| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022393 |
| Receipt No. | R000025753 |
| Official scientific title of the study | Effects of long-term ingestion of milk protein on body composition and physical capacity in high school students |
| Date of disclosure of the study information | 2016/05/23 |
| Last modified on | 2016/11/21 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effects of long-term ingestion of milk protein on body composition and physical capacity in high school students | |
| Title of the study (Brief title) | Effects of long-term ingestion of milk protein on body composition and physical capacity in high school students | |
| Region |
|
|
| Condition | ||
| Condition | Healthy person | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the effects of 12 weeks ingestion of milk protein drinks and control drinks on body composition and physical capacity in high school students |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skeletal muscle mass (after 12 weeks ingestion and change in 12 weeks) |
| Key secondary outcomes | Body height, body weight, body fat mass, time of 50 m dash, standing long jump length, throwing medicine ball length, grip strength, back muscle strength, leg extension strength, leg muscle thickness, feeling of fatigue
(after 12 weeks ingestion and change in 12 weeks) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 12 weeks ingestion of milk protein drinks (107 kcal, 10 g protein, 9.5 g carbohydrate, 3.2 g fat/bottle; 2 bottles/day) | |
| Interventions/Control_2 | 12 weeks ingestion of control drinks (104 kcal, 0.0 g protein, 26 g carbohydrate, 0.0 g fat/bottle; 2 bottles/day) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects giving written informed consent
2) High school students who belong to sports clubs |
|||
| Key exclusion criteria | 1) Seriously or progressive ill patients
2) Patients with milk or grape allergies 3) Subjects who were judged as unsuitable for this study by the doctor for other reasons |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Shuji Ikegami |
| Organization | Meiji Co., Ltd. |
| Division name | Sports Nutrition Research Department Food Science Research Laboratories R&D Division |
| Address | 540 Naruda, Odawara, Kanagawa 250-0862, Japan |
| TEL | +81-465-37-3796 |
| shuuji.ikegami@meiji.com | |
| Public contact | |
| Name of contact person | Chiaki Sanbongi |
| Organization | Meiji Co., Ltd. |
| Division name | Sports Nutrition Research Department Food Science Research Laboratories R&D Division |
| Address | 540 Naruda, Odawara, Kanagawa 250-0862, Japan |
| TEL | +81-465-37-3796 |
| Homepage URL | |
| chiaki.sanbongi@meiji.com | |
| Sponsor | |
| Institute | Meiji Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Meiji Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Bell Medical Solutions Inc. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025753 |